Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita

被引:147
|
作者
Vulliamy, TJ [1 ]
Knight, SW [1 ]
Mason, PJ [1 ]
Dokal, I [1 ]
机构
[1] Hammersmith Hosp, Imperial Coll Sch Med, Dept Haematol, London W12 0NN, England
关键词
ageing; aplastic anemia; DKC1; dyskeratosis congenita; dyskerin; telomeres; telomerase;
D O I
10.1006/bcmd.2001.0389
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dyskeratosis congenita (DC) is an inherited bone marrow failure syndrome in which patients undergo premature ageing and have a predisposition to malignancy. X-linked and autosomal (dominant and recessive) forms of the disease are recognized. The gene responsible for X-linked DC (DKC1) encodes a highly conserved protein called dyskerin that is believed to be essential in ribosome biogenesis and may also be involved in telomerase RNP assembly. Here we show that in X-linked DC, peripheral blood cells have dramatically reduced telomere lengths but normal levels of telomerase activity. We also find that subjects with autosomal DC have significantly shorter telomeres than age-matched normal controls suggesting that both forms of the disease are associated with rapid telomere shortening in hemopoietic stem cells. The further characterization of these genes will not only lead to a better understanding of the biology of DC but may also provide further insights into the maintenance of telomeres and the biology of aplastic anemia, ageing, and cancer. (C) 2001 Academic Press.
引用
收藏
页码:353 / 357
页数:5
相关论文
共 22 条
  • [1] Telomerase RNA deficiency in peripheral blood mononuclear cells in X-linked dyskeratosis congenita
    Judy M. Y. Wong
    Mouhammed J. Kyasa
    Laura Hutchins
    Kathleen Collins
    Human Genetics, 2004, 115 : 448 - 455
  • [2] Identification of DKC1 gene mutations in Japanese patients with X-linked dyskeratosis congenita
    Kanegane, H
    Kasahara, Y
    Okamura, J
    Hongo, T
    Tanaka, R
    Nomura, K
    Kojima, S
    Miyawaki, T
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (03) : 432 - 434
  • [3] Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita
    Wong, Judy M. Y.
    Collins, Kathleen
    GENES & DEVELOPMENT, 2006, 20 (20) : 2848 - 2858
  • [4] X-linked dyskeratosis congenita: restrictive pulmonary disease and a novel mutation
    Safa, WF
    Lestringant, GG
    Frossard, PM
    THORAX, 2001, 56 (11) : 891 - 894
  • [5] A novel missense mutation in the DKC1 gene in a Japanese family with X-linked dyskeratosis congenita
    Hiramatsu, H
    Fujii, T
    Kitoh, T
    Sawada, M
    Osaka, M
    Koami, K
    Irino, T
    Miyajima, T
    Ito, M
    Sugiyama, T
    Okuno, T
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2002, 19 (06) : 413 - 419
  • [6] Decreased dyskerin levels as a mechanism of telomere shortening in X-linked dyskeratosis congenita
    Parry, Erin M.
    Alder, Jonathan K.
    Lee, Stella S.
    Phillips, John A., III
    Loyd, James E.
    Duggal, Priya
    Armanios, Mary
    JOURNAL OF MEDICAL GENETICS, 2011, 48 (05) : 327 - 333
  • [7] A Patient With X-Linked Dyskeratosis Congenita Presenting With Bronchiolitis Obliterans Requiring Lung Transplantation and Immunodeficiency
    Goldfarb, Samuel
    Sullivan, Kathleen E.
    Jyonouchi, Soma
    PEDIATRIC PULMONOLOGY, 2013, 48 (01) : 91 - 93
  • [8] New Insights into Dyskerin-CypA Interaction: Implications for X-Linked Dyskeratosis Congenita and Beyond
    Belli, Valentina
    Maiello, Daniela
    Di Lorenzo, Concetta
    Furia, Maria
    Vicidomini, Rosario
    Turano, Mimmo
    GENES, 2023, 14 (09)
  • [9] Targeted disruption of Dkc1, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice
    Jun He
    Sandra Navarrete
    Murek Jasinski
    Tom Vulliamy
    Inderjeet Dokal
    Monica Bessler
    Philip J Mason
    Oncogene, 2002, 21 : 7740 - 7744
  • [10] Targeted disruption of Dkc1, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice
    He, J
    Navarrete, S
    Jasinski, M
    Vulliamy, T
    Dokal, I
    Bessler, M
    Mason, PK
    ONCOGENE, 2002, 21 (50) : 7740 - 7744